The difference between both groups of pathologies is based on clinical appearance, as rubor, improvement of movement etc. Both groups were combined based on consistent clinical observations.

​

Results:

Total: 201 patients (24.6%)

Pre-treatment average: VAS 1.2 points

Post treatment average: VAS 9.2 points

1 year post treatment average: VAS 9.0 points of maximum 10 points

​​​

Conclusion:

General health condition – health improvement according to the patient's subjective perception

 

Total: 817 (100 % - all patients with various indications)

Pre-treatment average: VAS 1.4 points

Post treatment average: VAS 9.5 points

1 year post treatment average: VAS 9.2 points of maximum 10 points

​

In summary, it can be stated that longevity, health condition and patients’ personal perception of well-being improved significantly after BMRT® Ultra High Dosage Antibody Therapy in all indications described.